当前位置： SCI文献检索 > CLINICAL THERAPEUTICS期刊下所有文献 > Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure.

Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure.

Abstract：

:Congestive heart failure (CHF) afflicts more than 4.6 million people in the United States and increases at a rate of 400,000 newly diagnosed patients per year. With more than 1.5 million hospital admissions per year attributed to CHF, it is the number one cause of hospitalization. Hospital length of stay (LOS) is one key determinant of greater hospital costs and has been the focus in some economic studies of CHF patients. In the present study, the potential economic benefits for hospitals from the implementation of improved disease-specific management programs in the treatment of CHF have been quantified in terms of LOS. We estimated the potential effects of disease management on LOS as a residual variation across hospitals, controlling for the effects of patient-specific characteristics, including severity of disease, health status, insurance status, and comorbidities. The study entry criteria and random sample selection yielded 5242 records for analysis. The average LOS was 7.1 days. The fixed effects or disease management practices across hospitals contribute to the explanatory power of the model by 4%. The 104 hospital-specific fixed effects measuring the potential impact of the differences in disease management relative to the reference hospital had values ranging from-3.41 to 4.33 days, for a total spread of 7.74 days, even after controlling for all other factors. The analysis suggests that the potential gain in profits for hospitals reimbursed on a per-case basis may be substantial, if disease management strategies practiced by those hospitals that lie to the left of the mean LOS were used by those that lie to the right of the mean LOS.

journal_name

Clin Ther

journal_title

Clinical therapeutics

authors

Simons WR,Haim M,Rizzo J,Zannad F

doi

10.1016/s0149-2918(96)80223-2

subject

Has Abstract

pub_date

1996-07-01 00:00:00

pages

726-46; discussion 702

issue

4

eissn

0149-2918

issn

1879-114X

pii

S0149-2918(96)80223-2

journal_volume

18

pub_type

杂志文章

相关文献

CLINICAL THERAPEUTICS文献大全
  • A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.

    abstract：BACKGROUND:Oxymorphone extended release (ER) is a tablet formulation of the mu-opioid agonist oxymorphone designed to achieve a low peak-to-trough fluctuation in plasma concentrations over a 12-hour dosing period. OBJECTIVE:This study compared the analgesic efficacy, dose response, and tolerability of 3 doses of oxymo...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2006.03.008

    authors： Kivitz A,Ma C,Ahdieh H,Galer BS

    更新日期：2006-03-01 00:00:00

  • Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.

    abstract：:Thirty children with serious gram-negative infections were treated with either netilmicin, 2 mg/kg, or tobramycin, 1 mg/kg, every eight hours for a minimum of 72 hours. Because of the administration of different doses, a "blind" investigator evaluated treatment response while another investigator adjusted the doses on...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章

    doi：

    authors： Weippl G

    更新日期：1983-01-01 00:00:00

  • Insulin glargine.

    abstract：BACKGROUND:In diabetes mellitus, the clinical goal of intensive glycemic control (lowering blood glucose concentrations to normal or near-normal levels) has been hindered by the lack of insulin regimens that duplicate the basal-bolus secretion of insulin by the healthy pancreas. In particular, intensive therapy has bee...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(01)80148-x

    authors： Campbell RK,White JR,Levien T,Baker D

    更新日期：2001-12-01 00:00:00

  • Clinically important drug-disease interactions and their prevalence in older adults.

    abstract：BACKGROUND:Older adults may have decreased homeostatic reserve, have multiple chronic diseases, and take multiple medications. Therefore, they are at risk for adverse outcomes after receiving a drug that exacerbates a chronic disease. OBJECTIVES:The aims of this study were to compile a list of clinically important dru...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2006.08.006

    authors： Lindblad CI,Hanlon JT,Gross CR,Sloane RJ,Pieper CF,Hajjar ER,Ruby CM,Schmader KE,Multidisciplinary Consensus Panel

    更新日期：2006-08-01 00:00:00

  • Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.

    abstract：:The objective of this study was to compare the lipid-altering efficacy and safety of simvastatin with that of gemfibrozil in hypercholesterolemic patients with non-insulin-dependent diabetes mellitus (NIDDM). The study was a 24-week, double-blind, randomized, multicenter trial conducted at clinics and hospitals in the...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/0149-2918(95)80018-2

    authors： Sweany AE,Shapiro DR,Tate AC,Goldberg RB,Stein EA

    更新日期：1995-03-01 00:00:00

  • Total Versus Subtotal Hysterectomy: Systematic Review and Meta-analysis of Intraoperative Outcomes and Postoperative Short-term Events.

    abstract：PURPOSE:The benefits and disadvantages of cervical extraction during hysterectomy are unclear in the literature. We intended to compare total (TH) with subtotal or supracervical (SH) hysterectomy regarding intraoperative and postoperative outcomes (quality of life, sexual function, pain and cyclical bleeding). METHODS...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,meta分析

    doi：10.1016/j.clinthera.2019.02.006

    authors： Aleixo GF,Fonseca MCM,Bortolini MAT,Brito LGO,Castro RA

    更新日期：2019-04-01 00:00:00

  • Glycemic Control Outcomes After Canagliflozin Initiation: Observations in a Medicare and Commercial Managed Care Population in Clinical Practice.

    abstract：PURPOSE:Although the efficacy of canagliflozin has been well established in clinical trials, research regarding its use and impact on outcomes in clinical practice has been limited by the availability of data on observations up to and beyond 6 months after the initial use of canagliflozin. The purpose of this study was...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2016.07.009

    authors： Bailey RA,Schwab P,Xu Y,Pasquale M,Renda A

    更新日期：2016-09-01 00:00:00

  • Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.

    abstract：:In an open, multicenter trial, 329 patients (who attended gastroenterology practices or outpatient gastroenterology departments of hospitals) with a mean age of 47.3 years, received 5 mg of cisapride three times a day (TID) for at least 2 weeks for the treatment of persistent, recurring symptoms of functional dyspepsi...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究

    doi：

    authors： Rösch W

    更新日期：1994-05-01 00:00:00

  • Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria.

    abstract：OBJECTIVES:The aims of this study were to determine the prevalence of prescribing potentially inappropriate medications (PIMs) based on the 2002 Beers criteria among ambulatory patients aged > or =65 years, to compare PIM prevalence rates based on the 1997 Beers criteria and Zhan criteria with the rate obtained using t...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2005.01.009

    authors： Viswanathan H,Bharmal M,Thomas J 3rd

    更新日期：2005-01-01 00:00:00

  • Do dipeptidyl peptidase IV (DPP-IV) inhibitors cause heart failure?

    abstract：PURPOSE:Although recent reports suggest an association between saxagliptin and an increased risk of admissions for heart failure, it is not clear whether dipeptidyl peptidase IV (DPP-IV) inhibition contributes to heart failure in high-risk patients. The purpose of this research is to understand heart failure risk among...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2014.10.009

    authors： Clifton P

    更新日期：2014-12-01 00:00:00

  • Estimating the Cost of Illness of Prostate Cancer in Iran.

    abstract：PURPOSE:Prostate cancer is the second most common cancer among men worldwide. In the past 10 years in Iran, prostate cancer has increased and become more common among hormone-related cancers. As the percentage of seniors in the population increases, the economic burden of this cancer will likely increase significantly....

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2018.11.001

    authors： Mojahedian MM,Toroski M,Keshavarz K,Aghili M,Zeyghami S,Nikfar S

    更新日期：2019-01-01 00:00:00

  • Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.

    abstract：PURPOSE:Intensive blood pressure (BP) lowering is important for the treatment of hypertension; however, it has been a challenge to achieve target BP in many patients. The purpose of this study was to explore the optimal dosage of a fixed-dose combination of candesartan cilexetil (CAN) and amlodipine besylate (AML), by ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2017.06.014

    authors： Sohn IS,Kim CJ,Ahn T,Youn HJ,Jeon HK,Ihm SH,Cho EJ,Chung WB,Chae SC,Kim WS,Nam CW,Park SM,Choi JY,Kim YK,Hong TJ,Lee HY,Cho JH,Shin ES,Yoon JH,Yang TH,Jeong MH,Lee JH,Park JI

    更新日期：2017-08-01 00:00:00

  • Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.

    abstract：:We compared the efficacy of timolol maleate ophthalmic gel-forming solution 0.5% QD with that of levobunolol hydrochloride 0.5% BID, as measured by change in intraocular pressure (IOP), effect on heart rate, and ocular tolerability. The study had a positive-controlled, double-masked, randomized, multicenter, 12-week, ...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/s0149-2918(98)80112-4

    authors： Walters TR,Maloney S,Slater D,Liss C,Wilson H,Hartenbaum D

    更新日期：1998-11-01 00:00:00

  • Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.

    abstract：BACKGROUND:Patients and physicians consider rapid onset of pain relief and pain freedom among the most important attributes of migraine therapy. OBJECTIVE:This study compared the effectiveness of rizatriptan 10 mg and usual-care oral migraine medications in everyday clinical practice settings. METHODS:This was a mult...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/j.clinthera.2006.06.006

    authors： Bell CF,Foley KA,Barlas S,Solomon G,Hu XH

    更新日期：2006-06-01 00:00:00

  • A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.

    abstract：:The efficacy and safety of Naprelan (naproxen sodium) 1000 mg once daily (QD) and nabumetone 1500 mg QD were compared in a multicenter, randomized, parallel-group, placebo-controlled, double-masked, 4-week study of adult outpatients with active osteoarthritis (OA) of the knee. Nabumetone 1500 mg was chosen for compari...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：10.1016/s0149-2918(97)80090-2

    authors： Fleischmann RM,Flint K,Constantine G,Kolecki B

    更新日期：1997-07-01 00:00:00

  • Sex-specific Outcomes in a Substance Use Intervention Program.

    abstract：PURPOSE:We performed an emergency department (ED)-based substance use screening, motivational interview-based intervention, and treatment referral program with the goal of determining sex-specific outcomes. Specifically, in this quality improvement project, we aimed to determine whether there was a difference among sex...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2020.01.020

    authors： Amaducci AM,Greenberg MR,Sheen AW,Warren HR,Parikh PM,Roth P,Weaver KR,Richardson DM,Burmeister DB,Stephens JL,Cannon RD

    更新日期：2020-03-01 00:00:00

  • Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

    abstract：BACKGROUND:Antidepressants have been commonly used by women of childbearing age. Recent studies suggest that paroxetine, a selective serotonin reuptake inhibitor (SSRI), might specifically increase teratogenic risk. OBJECTIVES:The purpose of this study was to quantify first-trimester exposure to paroxetine and birth d...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,meta分析,评审

    doi：10.1016/j.clinthera.2007.05.003

    authors： Bar-Oz B,Einarson T,Einarson A,Boskovic R,O'Brien L,Malm H,Bérard A,Koren G

    更新日期：2007-05-01 00:00:00

  • An In-home Advanced Robotic System to Manage Elderly Home-care Patients' Medications: A Pilot Safety and Usability Study.

    abstract：PURPOSE:We examined the safety profile and usability of an integrated advanced robotic device and telecare system to promote medication adherence for elderly home-care patients. METHODS:There were two phases. Phase I aimed to verify under controlled conditions in a single nursing home (n = 17 patients) that no robotic...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/j.clinthera.2017.03.020

    authors： Rantanen P,Parkkari T,Leikola S,Airaksinen M,Lyles A

    更新日期：2017-05-01 00:00:00

  • Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

    abstract：BACKGROUND:Therapeutic drug monitoring (TDM) is essential to maintain the efficacy of many immunosuppressant drugs while minimizing their toxicity. TDM has become more refined with the development of new monitoring techniques and more specific assays. OBJECTIVE:This article summarizes current data on TDM of the follow...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0149-2918(02)85038-x

    authors： Kahan BD,Keown P,Levy GA,Johnston A

    更新日期：2002-03-01 00:00:00

  • Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.

    abstract：BACKGROUND:Dual antiplatelet therapy with a thienopyridine (ticlopidine or clopidogrel) and aspirin is used to reduce the risk of late stent thrombosis and complications (myocardial infarction [MI] and death) after placement of a drug-eluting stent (DES). OBJECTIVE:This article reviews available clinical efficacy and ...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2011.01.003

    authors： Mohammad RA,Goldberg T,Dorsch MP,Cheng JW

    更新日期：2010-12-01 00:00:00

  • A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes

    abstract：BACKGROUND:Type 2 diabetes mellitus is twice as prevalent in African Americans and Hispanic Americans as in non-Hispanic whites. However, the effectiveness and safety profile of rosiglitazone maleate used as combination therapy with sulfonylureas in the management of diabetes and its effect on cardiovascular disease (C...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.clinthera.2007.09.011

    authors： Davidson JA,McMorn SO,Waterhouse BR,Cobitz AR

    更新日期：2007-09-01 00:00:00

  • Aripiprazole in schizophrenia and schizoaffective disorder: A review.

    abstract：BACKGROUND:During the past decade, there has been some progress in the pharmacotherapy of schizophrenia and schizoaffective disorder. Current evidence supports the use of various second-generation, or atypical, antipsychotic medications, although few of these agents have been associated with long-term efficacy and tole...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2010.01.021

    authors： Stip E,Tourjman V

    更新日期：2010-01-01 00:00:00

  • Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.

    abstract：PURPOSE:In patients with type 2 diabetes mellitus, fixed-dose combinations (FDCs) of antihyperglycemic medications may provide complementary efficacy while reducing tablet burden and improving compliance. The aim of this study was to assess the bioequivalence and tolerability of 2 FDCs of dapagliflozin and metformin ex...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2015.11.010

    authors： Boulton DW,Chang M,Griffen SC,Kitaura C,Lubin S,Pollack A,LaCreta F

    更新日期：2016-01-01 00:00:00

  • Treatment of chronic erosive gastritis: a double-blind trial of pirenzepine and cimetidine.

    abstract：:In a double-blind study, 59 patients with chronic erosive gastritis received 50 mg of pirenzepine twice daily and 55 patients received 400 mg of cimetidine twice daily for six weeks. In both groups, days of pain, of heartburn, and of nausea per week were significantly reduced during treatment (P less than 0.01). After...

    journal_title：Clinical therapeutics

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Dal Monte PR,D'Imperio N,Barillari A,Vezzadini P,Bensi G,Imbimbo BP

    更新日期：1989-11-01 00:00:00

  • Effects of dexamethasone in preventing postoperative emetic symptoms after total knee replacement surgery: a prospective, randomized, double-blind, vehicle-controlled trial in adult Japanese patients.

    abstract：BACKGROUND:Postoperative emetic symptoms (nausea, retching, and vomiting) are common following total joint replacement, with an incidence as high as 83% when no prophylactic antiemetic is provided. However, most antiemetics currently used in Japan, such as antihistamines (eg, hydroxyzine), butyrophenones (eg, droperido...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验,收录出版

    doi：10.1016/j.clinthera.2005.05.011

    authors： Fujii Y,Nakayama M

    更新日期：2005-06-01 00:00:00

  • A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

    abstract：BACKGROUND:Valproic acid has been associated with a highly variable intersubject absorptive phase; therefore, magnesium salt (magnesium valproate [MgV]) was developed to diminish variation during enteric absorption. OBJECTIVES:The aims of this study were to assess the pharmacokinetics of single oral doses of MgV 500-m...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.clinthera.2009.09.016

    authors： Marcelín-Jiménez G,Angeles-Moreno AP,Contreras-Zavala L,Morales-Martínez M,Rivera-Espinosa L

    更新日期：2009-09-01 00:00:00

  • Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers.

    abstract：:The subjects were 20 chronic schizophrenic patients with dyslipidemia (total cholesterol levels greater than or equal to 220 mg/dl, triglycerides greater than or equal to 150 mg/dl, or high-density lipoprotein cholesterol less than or equal to 40 mg/dl) who had been receiving neuroleptics for a mean of ten years. Each...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：

    authors： Sasaki J,Takada Y,Handa K,Kusuda M,Tanabe Y,Matsunaga A,Arakawa K

    更新日期：1990-05-01 00:00:00

  • Tolerability of antihypertensive drugs in a community-based setting.

    abstract：BACKGROUND:Outside the experimental environment of clinical trials, the tolerability of angiotensin-converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), and the angiotensin II antagonist losartan has not been compared. OBJECTIVES:The purpose of this study was to estimate, in current clinical practice...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章

    doi：10.1016/s0149-2918(01)80021-7

    authors： Grégoire JP,Moisan J,Guibert R,Ciampi A,Milot A,Côté I,Gaudet M

    更新日期：2001-05-01 00:00:00

  • Cardiovascular support in preterm infants.

    abstract：BACKGROUND:Despite increasing investigation in the area of cardiovascular instability in preterm infants, huge gaps in knowledge remain. None of the current treatments for hypotension, including the use of inotropic agents, have been well studied in the preterm population, and data regarding safety and efficacy are lac...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2006.09.006

    authors： Evans JR,Lou Short B,Van Meurs K,Cheryl Sachs H

    更新日期：2006-09-01 00:00:00

  • FlexPen: addressing issues of confidence and convenience in insulin delivery.

    abstract：BACKGROUND:In people with type 1 or type 2 diabetes, poor adherence to insulin therapy can compromise disease management. There are several reasons for poor adherence, including social embarrassment, inconvenience, needle anxiety, fear of injection pain, and complicated regimens. Attempts to facilitate implementation o...

    journal_title：Clinical therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.clinthera.2005.11.019

    authors： Korytkowski M,Niskanen L,Asakura T

    更新日期：2005-01-01 00:00:00